How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure?

Journal of Cardiac Failure

Volumn 11, Issue 7, 2005, Pages 534-541

  Middlekauff, Holly R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autonomic nervous system; Exercise; Heart failure; Pacemaker

Indexed keywords

ENALAPRIL; LOSARTAN;

ADAPTATION; ATTENUATION; AUTONOMIC DYSFUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG EFFECT; EXERCISE; EXHAUSTION; FATIGUE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART OUTPUT; HUMAN; INFLAMMATION; MALNUTRITION; MUSCLE BLOOD FLOW; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYMPATHETIC TONE; SYMPTOMATOLOGY;

CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LOCOMOTION; MUSCLE, SKELETAL; PACEMAKER, ARTIFICIAL; REGIONAL BLOOD FLOW; SYMPATHETIC NERVOUS SYSTEM;

EID: 25844449128     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.03.002     Document Type: Review

References (65)

1. J.R. Wilson, G. Rayos, T.K. Yeoh, P. Gothard, and K. Bak Dissociation between exertional symptoms and circulatory function in patients with heart failure Circulation 92 1995 47 53
2. J.R. Wilson, G. Rayos, T.K. Yeoh, and P. Gothard Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates J Am Coll Cardiol 26 1995 429 435
3. J.N. Cohn, G.R. Johnson, R. Shabetai, H. Loeb, F. Tristani, and T. Rector for the V-HeFT VA Cooperative Studies Group Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure Circulation 87 Suppl VI 1993 VI-V5 VI-V16
4. A.L. Clark, P.A. Poole-Wilson, and A.J.S. Coats Exercise limitation in chronic heart failure: central role of the periphery J Am Coll Cardiol 28 1996 1092 1102
5. R.S. McKelvie, K.K. Teo, N. McCartney, D. Humen, T. Montague, and S. Yusuf Effects of exercise training in patients with congestive heart failure: A critical review J Am Coll Cardiol 1995 789 796
6. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh for the MIRACLE Study Group Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
7. A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, and P. Bakker for the PATH-CHF Study Group Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033
8. C. Linde, C. Leclercq, S. Rex, S. Garrigue, T. Lavergne, S. Cazeau on behalf of the MUSTIC Study Group Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study J Am Coll Card 40 2002 111 118
9. J.B. Young, W.T. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, and B. Wilkoff for the MIRACLE ICD Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694
10. US Food and Drug Administration. Summary of safety and effectiveness: Guidant CONTAK-CD CRT-D System. Available from: http://www.fda.gov/cdrh/pdf/ p010012.html. Accessed July 12, 2004.
11. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. De Marco for the COMPANION Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
12. M.J. Sullivan, H.J. Green, and F.R. Cobb Altered skeletal muscle metabolic response to exercise in chronic heart failure: Relation to skeletal muscle aerobic enzyme activity Circulation 84 1991 1597 1607
13. R. Ventura-Clapier, E. De Sousa, and V. Veksler Metabolic myopathy in heart failure News Physiol Sci 17 2002 191 196
14. P.K. Lunde, I. Sjaastad, H.M. Schiotz Thorud, and O.M. Sejersted Skeletal muscle disorders in heart failure Acta Physiol Scand 171 2001 277 294
15. P.A. Poole-Wilson, and R. Ferraro Role of skeletal muscle in the syndrome of chronic heart failure J Mol Cell Cardiol 28 1996 2275 2285
16. D. Harrington, S.D. Anker, T.P. Chua, M. Webb-Peploe, P.P. Ponikowski, and P.A. Poole-Wilson Skeletal muscle function and its relation to exercise tolerance in chronic heart failure J Am Coll Cardiol 30 1997 1758 1764
17. B.M. Massie, M. Conway, B. Rajagopalan, R. Yonge, S. Frostick, and J. Ledingham Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow Circulation 78 1988 320 326
18. H. Drexler, U. Riede, T. Munzel, H. Konig, E. Funke, and H. Just Alterations of skeletal muscle in chronic heart failure Circulation 85 1992 1751 1759
19. J.R. Wilson, D.M. Mancini, and W.B. Dunkman Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure Circulation 87 1993 470 475
20. D.M. Mancini, J.R. Wilson, L. Bolinger, H. Li, K. Kendrick, and B. Chance In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with heart failure; demonstration of abnormal muscle metabolism despite adequate oxygenation Circulation 90 1994 500 508
21. G. Vescovo, R. Zennaro, M. Sandri, U. Carraro, C. Leprotti, and C. Ceconi Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure J Moll Cell Cardiol 30 1998 2449 2459
22. V. Adams, H. Jiang, J. Yu, S. Mobius-Winkler, E. Fiehn, and A. Linke Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance J Am Coll Cardiol 33 1999 959 965
23. C.C.W. Hsia Coordinated adaptation of oxygen transport in cardiopulmonary disease Circulation 104 2001 963 969
24. P.A. Srere Wanderings (wonderings) in metabolism Biol Chem Hoppe Seyler 374 1993 833 842
25. J. Diamond, and K. Hammond The matches, achieved by natural selection, between biological capacities and their natural loads Experimentia 48 1992 551 557
26. E. Gnaiger, B. Lassnig, A. Kuznetsov, G. Rieger, and R. Margreiter Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase J Exp Biol 201 1998 1129 1139
27. E.R. Weibel, C.R. Taylor, and H. Hoppeler The concept of symmorphosis: a testable hypothesis of structure-function relationship Proc Natl Acad Sci U S A 88 1991 10357 10361
28. G. Vescovo, F. Serfini, L. Facchin, P. Tenderini, U. Carraro, and L.D. Libera Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis Heart 76 1996 337 343
29. F.M. Franssen, E.F. Wouters, and A.M. Schols The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases Clin Nutr 21 2002 1 14
30. A. Simonini, C.S. Long, G.A. Dudley, P. Yue, J. McElhinny, and B.M. Massie Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity Circ Res 79 1996 128 136
31. G. Vescovo, L.D. Libera, F. Serafini, C. Leprotti, L. Facchin, and M. Volterrani Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition Circulation 98 1998 1742 1749
32. H. Drexler, U. Banhardt, T. Meinertz, H. Wollschlager, M. Lehmann, and H. Just Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: a double-blind, placebo-controlled trial Circulation 79 1989 491 502
33. S.D. Anker, P. Ponikowski, S. Varney, T.P. Chua, A.L. Clark, and K.M. Webb-Peploe Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
34. U. Muller-Wedan, and K. Werdan Immune modulation by catecholamines-a potential mechanism of cytokine release in heart failure? Herz 25 2000 271 273
35. C.E. Negrao, M.U.P.B. Rondon, T. Tinucci, M.J.N.A. Alves, F. Roveda, and A.M.W. Braga Abnormal neurovascular control during exercise is linked to heart failure severity Am J Physiol Heart Circ Physiol 280 2001 H1286 H1292
36. C.C. Lang, G.H. Rayos, D.B. Chomsky, A.J.J. Wood, and J.R. Wilson Effect of sympathoinhibition on exercise performance in patients with heart failure Circulation 96 1997 238 245
37. J.K. Shoemaker, H.L. Naylor, C.S. Hogemen, and L.I. Sinoway Blood flow dynamics in heart failure Circulation 99 1999 3002 3008
38. J.K. Shoemaker, P. Pandey, M.D. Herr, D.H. Silber, Q.X. Yang, and M.B. Smith Augmented sympathetic tone alters muscle metabolism with exercise: lack of evidence for functional sympatholysis J Appl Physiol 82 1997 1932 1938
39. M.J. Joyner, L.A. Nauss, M.A. Warner, and D.O. Warner Sympathetic modulation of blood flow and O2 uptake in rhythmically contracting human forearm muscles Am J Physiol 263 1992 H1078 H1083
40. H. Tsutue, T. Ide, S. Hayashidani, N. Suematsu, T. Shiomi, and J. Wen Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure Circulation 104 2001 134 136
41. M.B. Reid, and Y.P. Li Cytokines and oxidative signaling in skeletal muscle Acta Physiol Scand 171 2001 225 232
42. L.D. Libera, R. Sabbadini, C. Renken, B. Ravara, M. Sandri, and R. Betto Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine J Mol Cell Cardiol 33 2001 1871 1878
43. S. Gielen, V. Adams, S. Mobius-Winkler, A. Linke, S. Erbs, and J. Yu Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure J Am Coll Cardiol 42 2003 861 868
44. A.I. Larsen, S. Lindal, P. Aukrust, I. Toft, T. Aarsland, and K. Dickstein Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity Int J Cardiol 83 2002 25 32
45. G.A. MacGowan, D.L. Mann, R.L. Kormos, A.M. Feldman, and S. Murali Circulating interleukin-6 in severe heart failure Am J Cardiol 79 1997 1128 1131
46. T. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the SOLVD J Am Coll Cardiol 27 1996 1201 1206
47. K. Ostrowski, T. Rohde, M. Zacho, S. Asp, and B.K. Pedersen Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running J Physiol 508 1998 949 953
48. P.A. Baeuerle, and D. Baltimore NF-kappa-beta: ten years after Cell 87 1996 13 20
49. E. Jannson, P. Hjemdahl, and L. Kaijser Epinephrine-induced changes in muscle carbohydrate metabolism during exercise in male subjects J Appl Physiol 60 1986 1466 1470
50. O.J. Hartling, and J. Trap-Jansen Stimulation of beta-adrenoceptors in the exercising human forearm Clin Physiol 2 1982 363 371
51. E.A. Richter, N.B. Ruderman, and H. Galbo Alpha and beta adrenergic effects on metabolism in contracting, perfused muscle Acta Physiol Scand 116 1982 215 222
52. W.N. Stainsby, C. Sumners, and P.D. Eitzman Effects of catecholamines on lactic acid output during progressive working contractions J Appl Physiol 59 1985 1809 1814
53. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, and G.S. Francis Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
54. M.H. Hamdan, J.D. Zagrodzky, J.A. Joglar, C.J. Sheehan, K. Ramaswamy, and J.F. Erdner Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction Circulation 102 2000 1027 1032
55. M.H. Hamdan, S. Barbera, R.C. Kowal, R.L. Page, K. Ramaswamy, and J.A. Joglar Effects of resynchronization therapy on sympathetic activity inpatients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 1047 1051
56. P.B. Adamson, K.J. Kleckner, W.L. VanHout, S. Srinivasan, and W.T. Abraham Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure Circulation 108 2003 266 269
57. L.A. Saxon, T. De Marco, J. Schafer, K. Chatterjee, U.N. Kumar, E. Foster, and for the VIGOR-CHF Investigators Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling Circulation 105 2002 1304 1310
58. J.J. Blanc, V. Bertault-Valls, M. Fatemi, M. Gilard, P.Y. Pennec, and Y. Etienne Midterm benefits of left ventricular pacing in patients with congestive heart failure Circulation 109 2004 1741 1744
59. G. Grassi, A. Vincenti, R. Brambilla, F.Q. Trevano, R. Dell'Oro, and G. Trocino Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure Hypertension 44 2004 727 731
60. G. Grassi, and M. Esler How to assess sympathetic activity in humans J Hypertens 17 1999 719 734
61. H.R. Middlekauff, and A.L. Mark The treatment of heart failure: the role of neurohumoral activation Intern Med 37 1998 112 122
62. A.J.S. Coats, A.L. Clark, M. Piepoli, M. Volterrani, and P.A. Poole-Wilson Symptoms and quality of life in heart failure: the muscle hypothesis Br Heart J 72 Suppl 1994 S36 S39
63. D.W. Ferguson, W.J. Berg, P.J. Roach, R.M. Oren, and A.L. Mark Effects of heart failure on baroreflex control of sympathetic neural activity Am J Cardiol 69 1992 523 531
64. G.S. Nelson, R.D. Berger, B.J. Fetics, M. Talbot, J.C. Spinelli, and J.M. Hare Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block Circulation 102 2000 3053 3059
65. E. De Sousa, P. Lechene, D. Fortin, B. N'Guessan, S. Belmadani, and X. Bigard Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity Cardiovasc Res 56 2002 260 268